+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Angiox"

Angiox - API Insight, 2022 - Product Thumbnail Image

Angiox - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Angiox- Drug Insight, 2019 - Product Thumbnail Image

Angiox- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Angiox market is a segment of the cardiovascular drugs market, which includes drugs used to treat conditions related to the heart and blood vessels. Angiox drugs are used to treat a variety of conditions, including hypertension, coronary artery disease, and congestive heart failure. These drugs are typically administered orally or intravenously, and may be used in combination with other drugs to improve patient outcomes. Angiox drugs are designed to reduce the risk of stroke, heart attack, and other cardiovascular events. The Angiox market is highly competitive, with a number of major pharmaceutical companies offering products. These include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. Additionally, there are a number of smaller companies that specialize in the development and marketing of Angiox drugs. Show Less Read more